SMO and prostate cancer: Additionally, in a low-androgen environment, both cyclopamine and siRNA directed against SMO caused downregulation of androgen-regulated genes in prostate cancer cells while administration of exogenous GLI1 allowed cell growth in an androgen-deficient medium [14].